| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $63,199,145 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI163011 | Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization | 000 | 5 | NIH | 2/5/2026 | $545,212 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AR080096 | Mechanisms for Regenerative Healing in Intervertebral Discs | 000 | 5 | NIH | 2/12/2026 | $508,067 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AR078857 | Role of TNFalpha in discogenic pain progression and as a treatment target | 000 | 5 | NIH | 12/17/2025 | $576,100 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AR080616 | Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification | 000 | 5 | NIH | 1/21/2026 | $409,831 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA154947 | Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | 000 | 15 | NIH | 12/17/2025 | $578,878 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA244948 | Genetic Predictors of Prostate Cancer Survival | 000 | 6 | NIH | 12/22/2025 | $439,834 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG078657 | Identifying genetically driven gene dysregulation in Alzheimer's disease and related dementias using statistical data integration | 000 | 4 | NIH | 12/23/2025 | $603,742 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG087324 | Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease | 000 | 3 | NIH | 1/23/2026 | $508,112 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG082185 | The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease | 000 | 4 | NIH | 2/9/2026 | $1,969,360 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG072489 | Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease | 000 | 5 | NIH | 12/18/2025 | $1,057,227 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG075051 | A comprehensive study of tandem repeat variation as a cause of Alzheimer's disease | 000 | 2 | NIH | 1/30/2026 | $656,020 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 000 | 1 | NIH | 2/6/2026 | $575,377 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $552,728 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $163,927 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS143073 | Mapping the Epigenomic and Spatial Transcriptomic Landscape in Parkinson's Disease | 000 | 1 | NIH | 1/19/2026 | $670,266 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 000 | 2 | NIH | 12/19/2025 | $573,253 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 001 | 2 | NIH | 1/13/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS146414 | A Comprehensive Genetic, Transcriptomic, and Immunohistochemical Analysis of PSP | 000 | 1 | NIH | 2/2/2026 | $669,891 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 000 | 3 | NIH | 2/2/2026 | $618,303 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL162580 | Adaptive immunity regulates arteriovenous fistula remodeling | 000 | 5 | NIH | 2/9/2026 | $762,073 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL139963 | Increasing Ischemic Myocardial Tissue Perfusion by Mechanical LV Support | 000 | 9 | NIH | 2/16/2026 | $651,907 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL136255 | Mitochondria in the Regulation of Terminal Erythropoiesis | 000 | 8 | NIH | 2/9/2026 | $506,749 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173593 | Cardiac AAV gene delivery for clinical translation | 000 | 3 | NIH | 2/16/2026 | $761,593 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173456 | Microfluidic organoid model of cardio-hepatic physiology and disease | 000 | 3 | NIH | 2/16/2026 | $521,242 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 000 | 3 | NIH | 12/9/2025 | $477,398 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 000 | 5 | NIH | 12/30/2025 | $582,537 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES034864 | Cardiometabolic diseases in the World Trade Center general responder cohort and the role of subsequent environmental exposures | 000 | 4 | NIH | 1/21/2026 | $474,332 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 001 | 2 | NIH | 1/29/2026 | $118,029 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 000 | 2 | NIH | 1/27/2026 | $1,231,131 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 001 | 3 | NIH | 1/19/2026 | $69,858 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 000 | 3 | NIH | 1/13/2026 | $518,142 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD092990 | Extracellular regulation of Xenopus development | 000 | 7 | NIH | 1/21/2026 | $475,118 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 001 | 3 | NIH | 2/11/2026 | $70,391 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 000 | 3 | NIH | 12/2/2025 | $633,533 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK134773 | Genetic Analysis of Intrinsic Sensory Neuron Function in the Enteric Neural Circuits | 000 | 4 | NIH | 1/29/2026 | $598,796 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK129735 | Podocyte-specific Rap1 agonism for treatment of glomerular disease | 000 | 5 | NIH | 1/30/2026 | $618,264 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK131525 | Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | 000 | 5 | NIH | 12/23/2025 | $841,127 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK124133 | Uncovering the rules of gut microbiome strain transmission | 000 | 7 | NIH | 1/8/2026 | $617,193 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 8 | NIH | 2/16/2026 | $641,450 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK064640 | Transcription factors in kidney development | 000 | 21 | NIH | 12/18/2025 | $688,041 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK118222 | Mechanosensitive determinants of podocyte physiology | 000 | 7 | NIH | 1/8/2026 | $725,168 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 3 | NIH | 1/21/2026 | $331,100 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK141891 | Manufacture of defined live microbial therapeutics for infectious and inflammatory disease | 000 | 2 | NIH | 1/19/2026 | $671,511 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK137968 | The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention study | 000 | 3 | NIH | 12/22/2025 | $729,507 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139631 | Nrf2 and the expansion and preservation of beta cell mass | 000 | 3 | NIH | 2/16/2026 | $735,808 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK146762 | EYA1 as a novel regulator of HIV-induced end stage kidney disease | 000 | 1 | NIH | 2/13/2026 | $683,660 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32HL160511 | Multidisciplinary Research Training in Sleep Science | 000 | 4 | NIH | 1/31/2026 | $392,778 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1NS115268 | The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic Neurodegeneration | 000 | 2 | NIH | 2/10/2026 | $3,354,854 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AG073148 | A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | 000 | 5 | NIH | 1/6/2026 | $2,321,095 |
|
